|
|
 |
10th PRDTD - Speakers' presentations
SESSION 2 – BUILDING ON THE POLICY BASE OF THE LAST 10 YEARS TO ADVANCE POLICY IN THE NEXT 5 YEARS
How to increase the number of Rare disease therapies under Research & Development to cover unmet medical needs?
How to improve the success rate of OD Development between Orphan Drug Designation (ODD) and Marketing Authorisation?
How to provide sustainable access to OMP at national level?
SESSION 3 – RARE CANCERSIntroduction
How to address the needs of Patients with rare cancers? – Commonalities and differences with rare diseases.
Access (to information, timely and correct diagnosis, therapies including centres of excellence/HTA/reimbursement/multidisciplinary teams, patient mobility, etc)
|
|
|